Director Roberto Mignone Disposes $14.4M in TEVA Ordinary Shares via Affiliated Fund
TEVA PHARMACEUTICAL INDUSTRIES LTD
Subscribe to track TEVA
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
# Insider Trade Alert: TEVA PHARMACEUTICAL INDUSTRIES LTD ($TEVA)
**Insider:** Mignone Roberto (Director)
**Action:** Open Market Sale (Code: S)
**Date:** 2026-09-18
**Shares Sold:** 367,600
**Price per Share:** $39.06 (Weighted Average: $38.68 - $39.38)
**Total Value:** $14,356,801.80
**Ownership Nature:** Indirect (Swiftcurrent Master Fund Ltd. / Bridger Management, LLC)
**Remaining Indirect Position:** 0 shares
**Remaining Direct Position:** 119,807 shares
**Rule 10b5-1 Plan:** No
Comprehensive Analysis
Executive Summary
On September 22, 2026, Teva Pharmaceutical Industries Ltd. ($TEVA) director Roberto Mignone reported an open market sale of 367,600 ordinary shares conducted on September 18, 2026. The shares were sold at a weighted average price of $39.0555 (ranging between $38.68 and $39.38) for gross proceeds of approximately $14.36 million. The disposition was executed without the use of a Rule 10b5-1 trading plan.
Transaction & Entity Context
The sold shares were held indirectly through Swiftcurrent Master Fund Ltd., where Bridger Management, LLC serves as investment adviser and Mr. Mignone serves as manager. This disposition fully liquidated the fund's reported indirect position in TEVA ordinary shares (reducing indirect holdings from 367,600 to 0). Mr. Mignone continues to hold 119,807 ordinary shares directly.
Market Implications
A complete indirect exit valued at over $14 million by an active board member and hedge fund manager warrants attention. While directors affiliated with investment vehicles periodically reallocate capital for fund-specific portfolio management reasons, significant open-market selling outside a scheduled 10b5-1 plan can introduce downward sentiment pressure.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.